Janssen Reports Positive 2-Year Results for Stelara as Crohn’s Treatment
News
Janssen-Cilag International reported results from its ongoing IM-UNITI long-term extension (LTE) clinical trial assessing the efficacy and safety of subcutaneous (SC) Stelara (ustekinumab) in patients with moderate to severe Crohn’s ... Read more